创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

column
Advantages and Challenges of Radionuclide Coupled Drugs Development
HONG Hao
2023, 47(5): 321-323. DOI: 10.20053/j.issn1001-5094.2023.05.001
Abstract PDF
Research Progress and Clinical Application of Radionuclide Drug Conjugates
DONG Guosheng, CHEN Xin, LI Kexin, ZHANG Tao
2023, 47(5): 324-336. DOI: 10.20053/j.issn1001-5094.2023.05.002
Abstract PDF
Research Progress of Radiopharmaceuticals Targeting Fibroblast Activation Protein in the Diagnosis and Treatment of Malignant Tumors
SONG-YANG Meihui, LI Mengting, LAN Xiaoli, JIANG Dawei
2023, 47(5): 337-356. DOI: 10.20053/j.issn1001-5094.2023.05.003
Abstract PDF
Progress in the Application of Radiolabeled Protein Drug in the Evaluation of PD-1/PD-L1 Targeted Immunotherapy
HUANG Wenpeng, SUN Xinyao, YANG Qi, SONG Lele, KANG Lei
2023, 47(5): 357-369. DOI: 10.20053/j.issn1001-5094.2023.05.004
Abstract PDF
Recent Advances of Radioimmunotherapy in Tumor Diagnosis and Treatment
XU Dongsheng, DUN Yiting, ZHANG You, WEI Weijun, LIU Jianjun
2023, 47(5): 370-378. DOI: 10.20053/j.issn1001-5094.2023.05.005
Abstract PDF
Pathogenesis and Drug Treatment Progress of Disseminated Intravascular Coagulation
FENG Yue, WANG Jing, LI Xinxin, MA Xiaohui, HU Qinghua
2023, 47(5): 379-391. DOI: 10.20053/j.issn1001-5094.2023.05.006
Abstract PDF
Research Progress of Glucocorticoid Receptor and New Glucocorticoid Receptor Modulators
WANG Dingding, GE Xiaoai, CHENG Liyuan, ZHANG Yujian, WANG Tao
2023, 47(5): 392-附页4. DOI: 10.20053/j.issn1001-5094.2023.05.007
Abstract PDF